SCHEMBL27950237

SCHEMBL27950237

Cc1c(Cc2ccc(C(=O)O)cc2)n(S(=O)(=O)CC=Cc2cccc(C(C)(C)C)c2)c2ccc(C(F)(F)F)cc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 1/20 0.37
▸ NPC1 O15118 1/20 0.37
▸ RAB9A P51151 1/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ PTGES2 Q9H7Z7 1/20 0.36
▸ MAOB P27338 2/20 0.35
▸ MAOA P21397 1/20 0.35
▸ CPT2 P23786 1/20 0.35
▸ CPT1A P50416 1/20 0.35
▸ CPT1B Q92523 1/20 0.35
▸ IDH1 O75874 1/20 0.35
▸ SRD5A2 P31213 1/20 0.35
▸ NLRP3 Q96P20 2/20 0.34
▸ P4HB P07237 1/20 0.34
▸ HTT P42858 1/20 0.34
▸ CYP3A4 P08684 1/20 0.34
▸ CYP2D6 P10635 1/20 0.34
▸ CYP2C9 P11712 1/20 0.34
▸ CYP2C19 P33261 1/20 0.34
▸ NR1H4 Q96RI1 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27936131 0.93 MRGPRX4 (0.37) MEN1NPC1RAB9AKMT2APTGES2
SCHEMBL27936040 0.86 ITK (0.33) PTGES2MAOBMAOAHTTCYP3A4
SCHEMBL28807365 0.84 PTGER1 (0.40) PTGES2P4HBHTTCYP3A4CYP2D6
SCHEMBL27936024 0.84 PPARG (0.39) MEN1NPC1RAB9AKMT2ASRD5A2
SCHEMBL12096810 0.83 POLB (0.41) PTGES2CPT2CPT1ACPT1BIDH1
SCHEMBL28810371 0.83 MEN1 (0.36) MEN1NPC1RAB9AKMT2AMAOB
SCHEMBL28947517 0.81 HTT (0.33) MEN1KMT2AMAOBMAOAHTT
Piperazine SCHEMBL27950239 0.80 PPARG (0.36) MEN1NPC1RAB9AKMT2AMAOB
SCHEMBL28947331 0.79 MAPT (0.36) MEN1NPC1RAB9AKMT2A
SCHEMBL27936059 0.78 MEN1 (0.36) MEN1NPC1RAB9AKMT2AMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103554006-A Use of indole derivatives as nurr-1 activators for the application thereof as a medicament for the treatment of parkinson's disease FOURNIER LAB SA 2014-02-05 — — CN claimed
CN-103554006-A Use of indole derivatives as nurr-1 activators for the application thereof as a medicament for the treatment of parkinson's disease FOURNIER LAB SA 2014-02-05 — — CN disclosed
Send feedback